Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 328-335, 2005. First published December 8, 2004; 10.1373/clinchem.2004.041764
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.041764v1
51/2/328    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poon, T. C.W.
Right arrow Articles by Sung, J. J.Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poon, T. C.W.
Right arrow Articles by Sung, J. J.Y.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2005;51:328-335.)
© 2005 American Association for Clinical Chemistry, Inc.

Proteomics and Protein Markers

Prediction of Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Infection by Serum Proteomic Fingerprinting: A Pilot Study

Terence C.W. Poon1,a, Alex Y. Hui1, Henry L.Y. Chan1, Irene Ling Ang1, Shuk Man Chow1, Nathalie Wong2 and Joseph J.Y. Sung1

Departments of1 Medicine and Therapeutics, and 2 Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong Special Administrative Region, China.

aAddress correspondence to this author at: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing St., Shatin, New Territories, Hong Kong Special Administrative Region, China. Fax 852-2648-8842; e-mail tcwpoon{at}cuhk.edu.hk.

Background: Most noninvasive predictive models of liver fibrosis are complicated and have suboptimal sensitivity. This study was designed to identify serum proteomic signatures associated with liver fibrosis and to develop a proteome-based fingerprinting model for prediction of liver fibrosis.

Methods: Serum proteins from 46 patients with chronic hepatitis B (CHB) were profiled quantitatively on surface-enhanced laser desorption/ionization (SELDI) ProteinChip arrays. The identified liver fibrosis-associated proteomic fingerprint was used to construct an artificial neural network (ANN) model that produced a fibrosis index with a range of 0–6. The clinical value of this index was evaluated by leave-one-out cross-validation.

Results: Thirty SELDI proteomic features were significantly associated with the degree of fibrosis. Cross-validation showed that the ANN fibrosis indices derived from the proteomic fingerprint strongly correlated with Ishak scores (r = 0.831) and were significantly different among stages of fibrosis. ROC curve areas in predicting significant fibrosis (Ishak score ≥3) and cirrhosis (Ishak score ≥5) were 0.906 and 0.921, respectively. At 89% specificity, the sensitivity of the ANN fibrosis index in predicting fibrosis was 89%. The sensitivity for prediction increased with degree of fibrosis, achieving 100% for patients with Ishak scores >4. The accuracy for prediction of cirrhosis was also 89%. Inclusion of International Normalized Ratio, total protein, bilirubin, alanine transaminase, and hemoglobin in the ANN model improved the predictive power, giving accuracies >90% for the prediction of fibrosis and cirrhosis.

Conclusions: A unique serum proteomic fingerprint is present in the sera of patients with fibrosis. An ANN fibrosis index derived from this fingerprint could differentiate between different stages of fibrosis and predict fibrosis and cirrhosis in CHB infection.




The following articles in journals at HighWire Press have cited this article:


Home page
 Physiol. Rev.Home page
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev, January 1, 2008; 88(1): 125 - 172.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
L. Huwart, C. Sempoux, N. Salameh, J. Jamart, L. Annet, R. Sinkus, F. Peeters, L. C. ter Beek, Y. Horsmans, and B. E. Van Beers
Liver Fibrosis: Noninvasive Assessment with MR Elastography versus Aspartate Aminotransferase to-Platelet Ratio Index
Radiology, November 1, 2007; 245(2): 458 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. K.T. Kam, T. C.W. Poon, H. L.Y. Chan, N. Wong, A. Y. Hui, and J. J.Y. Sung
High-Throughput Quantitative Profiling of Serum N-Glycome by MALDI-TOF Mass Spectrometry and N-Glycomic Fingerprint of Liver Fibrosis
Clin. Chem., July 1, 2007; 53(7): 1254 - 1263.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. T.K. Pang, T. C.W. Poon, K.C. A. Chan, N. L.S. Lee, R. W.K. Chiu, Y.-K. Tong, R. M.Y. Wong, S. S.C. Chim, S. M. Ngai, J. J.Y. Sung, et al.
Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome
Clin. Chem., March 1, 2006; 52(3): 421 - 429.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.